Bone Marrow Transplant From Related Donor for Patients With High Risk Hemoglobinopathies

NCT00040469 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

15

Enrollment

OTHER

Sponsor class

Stopped accrual was slow and sporadic so the study was closed

Conditions

Sickle Cell Anemia
Hemoglobinopathy
Thalassemia

Interventions

DRUG: Campath -1H
DRUG: Dilantin
DRUG: Busulfan
DRUG: Cyclophosphamide

Sponsor

Baylor College of Medicine

Collaborators

[object Object]
[object Object]